+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07589413

Predicting Recurrence and Progression Risk After Bladder Tumor Surgery Using Intraoperative Fluid Absorption and Blood DNA Changes

Led by Zhiping Wang · Updated on 2026-05-15

150

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the relationship between the amount of irrigation fluid absorbed during transurethral resection of bladder tumor TURBT surgery and changes in cell-free DNA cfDNA levels in patients with suspected or confirmed bladder cancer. This observational study aims to understand how intraoperative fluid absorption might influence tumor-related molecular changes and postoperative outcomes such as recurrence and progression. Participants scheduled for TURBT will have their irrigation fluid absorption volume measured during surgery using a dedicated system. Blood samples will be collected before and within 24 hours after surgery to analyze cfDNA levels and tumor-related mutations. Tumor tissue mutation status will also be assessed when available. This study does not involve changes to standard treatment and focuses on data collection and analysis. Participants will be followed postoperatively for oncological outcomes including recurrence, progression, and metastasis. Researchers will collect clinicopathological data, operative details, and cfDNA results to evaluate associations. The primary outcome is the change in plasma cfDNA level from before to within 24 hours after TURBT. Secondary outcomes include detection rates of tumor-related mutations and links to tumor characteristics. The study will help improve understanding of perioperative molecular changes and support better risk assessment and follow-up strategies for bladder cancer patients.

CONDITIONS

Brief Title

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here